Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
Dosing of a first patient in the CONVERGE study, a Phase 2 randomized controlled clinical trial for patients with stage 3 unresectable non-small cell lung cancerPresentation of data at the European Lung Cancer Conference in a Phase 1 study of re-irradiation with JNJ-1900 (NBTXR3) in locoregional recurrent NSCLC and a Phase 1 study of JNJ-1900 (NBTXR3) in combination with nivolumab or pembrolizumab for patients with lung metastases from NSCLC or other solid tumorsStrengthened financial...
Nasdaq GlobeNewswire
21/05/2025
BCC Research Forecasts Neurology Market to Reach $94.8 Billion by 2029
This report covers the market's current and future potential and examines market drivers and constraints, pipeline medications, the competitive landscape, the regulatory picture, and the epidemiology of neurological disorders. The study segments the market by disease indications, including Parkinson's, Alzheimer's, psychotic disorders, epilepsy, autism, multiple sclerosis, and brain tumors, with therapeutic and regional analysis for each. It also profiles smarket participants and competitors…
PR Newswire
21/05/2025
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA…
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA TechnologiesOSE Immunotherapeutics to lead French consortium with Inside Therapeutics and MiNT Laboratory (University of Angers) secures €1.3 million in funding fromBpifrance and Région Pays de la Loire NANTES, France – May 21, 2025, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announces a strategic collaboration with Angoulême/Bordeaux- based Inside Therapeutics and...
Nasdaq GlobeNewswire
21/05/2025
Ipsen S.A. - Annual General Meeting held on 21 May 2025
Annual General Meeting of Ipsen S.A. held on 21 May 2025All the resolutions submitted to the shareholders' vote have been adopted PARIS, FRANCE, 21 May 2025 -Ipsen (Euronext: IPN; ADR: IPSEY) announces today that the Annual General Meeting of the Company was held on Wednesday 21 May, 2025 at theSalons de l'Hôtel des Arts et Métiers, 9 bis, avenue d'Iéna, 75116 Paris (France), under the chairmanship of Mr. Marc de GARIDEL, Chairman of the Board of Directors,...
Nasdaq GlobeNewswire
21/05/2025
Combined General Meeting of May 21, 2025
Press Release - Approval of all resolutions submitted by the Board of Directors, including the unconsolidated and consolidated financial statements for the year 2024 - Paris – May 21, 2025– The Combined General Shareholders' Meeting of EUROAPI was held on May 21, 2025 in Paris, under the chairmanship of Emmanuel Blin. All resolutions put forth to a vote were adopted by the shareholders. The General Meeting approved the unconsolidated and consolidated financial...
Nasdaq GlobeNewswire
21/05/2025
Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe…
MEDIA RELEASE Pyzchiva® first ustekinumab biosimilar in Europe commercially available in pre-filled pen (autoinjector), offering improved self-administration experience for better treatment adherence and quality of life [1-10]Autoinjector includes unique features to improve comfort, independence and convenience for patients with chronic inflammatory diseases [1-10]Launch strengthens Sandoz biosimilar leadership position in immunology and commitment to patient-centric innovation...
Nasdaq GlobeNewswire
21/05/2025
AI In Healthcare Market Revenue worth $187.7 Billion by 2030 - Exclusive Study…
Market Overview and Growth Trajectory: Market Overview and Growth Trajectory: AI In Healthcare Market Growth: According to an exhaustive report by The Research Insights, the AI In Healthcare Market is experiencing significant growth, due to early detection of diseases significantly reduces mortality rates because early diagnosis leads to better survival outcomes while also cutting down treatment expenses. Resource-poor areas frequently experience late diagnosis of chronic diseases...
PR Newswire
21/05/2025
Lethal mutations in pregnancy loss
As part of a Nordic collaboration, scientists from deCODE genetics sought to answer these questions by sequencing 467 samples from pregnancy losses from a prospective study initiated by Henriette Svarre Nielsen and Eva R. Hoffmann. As part of a Nordic collaboration, scientists from deCODE genetics sought to answer these questions by sequencing 467 samples from pregnancy losses from a prospective study initiated by Henriette Svarre Nielsen and Eva R. Hoffmann . Interestingly, by...
PR Newswire
21/05/2025
Novo Nordisk Foundation enters into strategic framework agreement with the World…
The Foundation and WHO are deepening the partnership, adopting a more strategic approach through the signature of a framework agreement that will enable the two organisations to accelerate progress by working together. The Foundation and WHO are deepening the partnership, adopting a more strategic approach through the signature of a framework agreement that will enable the two organisations to accelerate progress by working together. This includes opportunities to collaborate on the...
PR Newswire
21/05/2025
Artificial Intelligence in Diagnostics Market Size worth US$ 5.44 billion by…
The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the Artificial Intelligence in Diagnostics Market growth of 22.46% comprises a vast array of Component, Diagnosis and Geography which are expected to register strength during the coming years. The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the Artificial Intelligence in Diagnostics Market growth of 22.46% comprises a vast array of...
PR Newswire
21/05/2025
Liquid Handling System Market worth US$7.4 billion by 2030 with 8.0% CAGR |…
Browse in-depth TOC on "Liquid Handling System Market" Browse in-depth TOC on "Liquid Handling System Market" 350 - Tables50 - Figures400 - Pages By Based on type,the liquid handling system market is segmented into automated, electronic, and manual systems. The automated liquid handling system segment dominates the market at present. The growth is driven by the widespread use of these systems in pharmaceutical and biotechnology companies, owing to their speed, accuracy,...
PR Newswire
21/05/2025
Ablation Technology Market Worth USD 16.74 Billion by 2034 With 9.82% CAGR |…
Download PDF Brochure:https://www.astuteanalytica.com/request-sample/ablation-technology-market Download PDF Brochure: https://www.astuteanalytica.com/request-sample/ablation-technology-market Structural technology shifts are deepening this procedural surge. The ablation technology market draws strength from wider single-shot catheter adoption that cuts average lab time by seventeen minutes according to aDecember 2023EP Europace study of 42 centers. More than 4 100 electrophysiology...
PR Newswire
21/05/2025
Genmab to Participate in a Fireside Chat at the 2025 Jefferies Global Health…
Media ReleaseCOPENHAGEN, Denmark; May 21, 2025 Genmab A/S (Nasdaq:GMAB) announced today thatits Chief Development Officer Judith Klimovsky will participate in a fireside chat at the 2025 Jefferies Global Health Care Conference in New York City, New York at 9:20 EDT (3:20 PM CEST) on June 5 , 2025. A webcast of the fireside chat will be available on Genmab's website athttps://ir.genmab.com/events-presentations. About Genmab Genmab is an...
Nasdaq GlobeNewswire
21/05/2025
Introducing BI•Q™: Brand Institute's Suite of AI-Powered Branding Solutions
"We've always believed that great branding starts with insight and sharp execution," said Jim Dettore, Chairman and CEO of Brand Institute. "We've always believed that great branding starts with insight and sharp execution," saidJim Dettore, Chairman and CEO of Brand Institute. One of the biggest opportunities in developing AI solutions is the ability to leverage the specialized knowledge of Brand Institute's regulatory team, which includes former government officials from…
PR Newswire
21/05/2025
Kailo Medical Acquires REI AI to Transform the Future of Radiology Reporting
At the heart of this acquisition lies a shared philosophy: that meaningful technology begins with deep understanding. Both companies are rooted in clinical insight and built with a clear focus on supporting radiologists. With REI AI, Kailo expands its capabilities to include generative reporting technology that will seamlessly integrate into clinical workflows, unlocking new levels of speed, clarity, and consistency. At the heart of this acquisition lies a shared philosophy: that meaningful...
PR Newswire
21/05/2025
Personal Protective Equipment Market worth $77.66 billion by 2030 - Exclusive…
Browse in-depth TOC on "Personal Protective Equipment Market" Browse in-depth TOC on "Personal Protective Equipment Market" 280 – Tables 60 – Figures 250 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132681971 The increased demand for PPE is additionally supported by global industrial expansion, tighter workplace safety regulations, and greater awareness of occupational health. Regulatory forces regarding employee safety and...
PR Newswire
21/05/2025
International and Regional Experts Focus on RSV Prevention at Pfizer MERA…
Professor Irene Cetin, Professor of Obstetrics and Gynecology, University of Milan and Head of Obstetrics, Mangiagalli Policlinico Hospital Fondazione IRCCS Cà Granda, Milan, Italy, said: "Maternal immunization leverages the natural pregnancy process whereby antibodies – disease-fighting molecules – pass naturally from mother to baby through the placenta, starting in the second trimester and peaking during the third. Maternal antibodies help protect infants at birth and during the first few…
PR Newswire
21/05/2025
Zymeworks Announces Participation in Upcoming Investor Conferences
Jefferies Global Healthcare Conference: Zymeworks' management will participate in one-on-one meetings and a fireside chat on June 4 at 2:35 pm Eastern Time (ET) in New York, NY.Goldman Sachs Global Healthcare Conference: Zymeworks' management will participate in one-on-one meetings and a fireside chat on June 11 at 2:00 pm ET in Miami, FL.Citi European Healthcare Conference: Zymeworks' management will participate in one-on-one meetings on June 17 in London, UK. About Zymeworks Inc...
Nasdaq GlobeNewswire
21/05/2025
Curium and NRG PALLAS extend collaboration in the supply of essential medical…
Global supply of technetium-99m, most widely used medical isotopes in nuclear medicine, is secured for the coming years More Than 50 Million Diagnosis Annually Technetium-99m is used for hospitals and patients. More than 50 million nuclear medicine procedures are performed each year, with technetium-99m used in more than 80% of these diagnosis. The multi-year agreement between NRG PALLAS and Curium is essential to ensure the continuity of medical isotope supply. Peter Luijten, CEO NRG...
Nasdaq GlobeNewswire
21/05/2025
FREESMO Supercharges Support for First-Time Switchers with New Amazon Voucher…
"We've taken everything our customers loved about the Golden Ticket campaign and made it better," said Georgi Keckarovski, CEO of FREESMO. "We've taken everything our customers loved about the Golden Ticket campaign and made it better," said Georgi Keckarovski, CEO of FREESMO. "We're not just rewarding luck, we're rewarding action. If you're ready to switch to a better alternative, we're ready to help, and that support now comes with a guaranteed reward." The…
PR Newswire
21/05/2025
Invitation to presentation of Sectra's year-end report 2024/2025
To participate, follow the instructions on Sectra's website investor.sectra.com/q4report2425. The broadcast will be made available on the same webpage after the conference. To participate, follow the instructions on Sectra's websiteinvestor.sectra.com/q4report2425. The broadcast will be made available on the same webpage after the conference. Participation will take place via Microsoft Teams. Questions can be posed using the chat function or by sending questions in advance via email to...
PR Newswire
21/05/2025
ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and…
Groundbreaking procedures extend ONWARD's leadership in the rapidly emerging brain-computer interface (BCI) fieldARC-BCI Therapy is designed to restore thought-driven movement after spinal cord injury and other movement disabilitiesONWARD's BCI breakthroughs were recently featured on CBS 60 Minutes with Anderson Cooper EINDHOVEN, the Netherlands, May21, 2025(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company...
Nasdaq GlobeNewswire
21/05/2025
WHO Foundation and Laerdal Global Health announce US $12.5 million to launch…
Laerdal Global Health founder, Tore Laerdal and WHO Foundation Chair, Thomas Zeltner announced the US $12.5 million commitment at an event during the World Health Assembly in Geneva on Tuesday 20th May 2025. Laerdal Global Health founder, Tore Laerdal and WHO Foundation Chair,Thomas Zeltnerannounced the US$12.5 millioncommitment at an event during the World Health Assembly inGenevaon Tuesday20th May 2025. This contribution includes support for WHO Basic Emergency Care training...
PR Newswire
21/05/2025
IBA and PET Pharm Bio sign contract to install a Cyclone® IKON in Taiwan
The Cyclone ®IKON is IBA's high energy and high-capacity cyclotronwhich offers the largest energy spectrum for the production of PET and SPECT isotopes from 13 MeV to 30 MeVLouvain-La-Neuve, Belgium, May 21, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of radiopharmaceutical production solutions, announces it has signed a contract with PET Pharm Bio to install a PET and SPECT isotopes...
Nasdaq GlobeNewswire
21/05/2025
Altri Comunicati